{"schema_version":"1.0","type":"article","title":"醫療巨頭分拆潮？","url":"https://drugnews.com.tw/articles/2026-04-26-dcard-261370593.html","markdown_url":"https://drugnews.com.tw/articles/2026-04-26-dcard-261370593.md","lang":"zh-Hant","date":"2026-04-26","publish_at":"2026-04-26T10:30:00+08:00","updated_at":"2026-04-26","category":"商業分析系列","topic":"商業分析系列","tags":["商業分析系列","免費文章","BD","生技投資"],"summary":"這幾年，全球大型企業在醫療產業做了一個很有意思、而且愈來愈頻繁的動作：把原本放在大集團裡的醫療業務拆出來，讓它獨立上市、獨立融資、獨立做決策。","key_points":[],"facts":[],"sections":["🔹一、Solventum：3M 斷開醫療業務後，市場為什麼重新開始認真看它？","🔹二、GE HealthCare 與 Siemens Healthineers：真正把分拆做成「成長放大器」的，是醫材","🔹三、Kenvue 與 Haleon：不是每一種醫療相關業務，拆出來都會變更好","🔹四、真正賺到的，很多時候反而是母公司","🔹五、所以，誰賺翻了？誰後悔了？","🔹六、下一個會是誰？"],"references":[{"title":"[0]: 各公司官網＆公開資料","source":"","date":"","url":""},{"title":"[1]:","source":"","date":"","url":""},{"title":"3M Completes Spin-off of Solventum - Apr 1, 2024","source":"","date":"","url":""},{"title":"Today, 3M completed the planned spin-off of its health care business, which formally launches Solventum Corporation as an independent company. Solventum is listed on the New York Stock Exchange as...","source":"","date":"","url":""},{"title":"news.3m.com","source":"","date":"","url":""},{"title":"[2]:","source":"","date":"","url":""},{"title":"3M Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Health Care Business as Solventum - Feb 21, 2024","source":"","date":"","url":""},{"title":"3M (NYSE: MMM) today announced the filing of a Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) for the planned spin-off of its Health Care business as the...","source":"","date":"","url":""},{"title":"news.3m.com","source":"","date":"","url":""},{"title":"[3]:","source":"","date":"","url":""},{"title":"Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance :: Solventum Corporation (SOLV","source":"","date":"","url":""},{"title":"Reported sales increased 1.9% to $2.074 billion; organic sales increased 2.3% GAAP diluted Earnings Per Share (EPS) of $0.17; adjusted EPS1 of…...","source":"","date":"","url":""},{"title":"investors.solventum.com","source":"","date":"","url":""},{"title":"[4]:","source":"","date":"","url":""},{"title":"Thermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business","source":"","date":"","url":""},{"title":"Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the comp","source":"","date":"","url":""},{"title":"ir.thermofisher.com","source":"","date":"","url":""},{"title":"[5]:","source":"","date":"","url":""},{"title":"\"GE HealthCare reports fourth quarter and full year 2025 financial results","source":"GE HealthCare\"","date":"","url":""}],"images":[{"alt":"Dcard 原圖：醫療巨頭分拆潮？（圖 1）","url":"https://drugnews.com.tw/assets/articles/dcard-261370593/dcard-01.webp"},{"alt":"Dcard 原圖：醫療巨頭分拆潮？（圖 2）","url":"https://drugnews.com.tw/assets/articles/dcard-261370593/dcard-02.png"},{"alt":"Dcard 原圖：醫療巨頭分拆潮？（圖 3）","url":"https://drugnews.com.tw/assets/articles/dcard-261370593/dcard-03.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/dcard-261370593/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-04-26）。醫療巨頭分拆潮？。https://drugnews.com.tw/articles/2026-04-26-dcard-261370593.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-04-26-dcard-261370593-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}